Heart Rate Variability, Physical Activity and Exhaustion in the Inpatient Treatment of Stress-Related Disorders

NCT05874856 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2023-05-25

No results posted yet for this study

Summary

The goal of this observational study is to learn about heart rate variability and physical activity in inpatients with stress-related disorder. The main questions to answer are:

* whether heart rate variability shows the severity of certain symptoms.
* whether physical activity has an influence on heart rate variability and symptoms of stress-related disorder.

Participants will be asked to take part in 5 examinations during their up to 8-week inpatient treatment:

* Participate in an interview
* Measurement of heart rate variability, blood pressure and health of the arteries (pulse wave velocity)
* Tests of endurance, strength, balance and cognitive abilities
* Completion of two additional short questionnaires
* Wearing a 24-hour electrocardiogram
* Wearing a fitness watch and daily self-assessment of fatigue, mood and tension via an app on participant's mobile phone during their stay.

Conditions

Interventions

DIAGNOSTIC_TEST

Heart rate variability, blood pressure and pulse wave velocity

Resting HRV in supine and standing position, blood pressure and pulse wave velocity in supine position at first and last week of inpatient treatment

DIAGNOSTIC_TEST

Assessment of cognitive function, balance, strength and cardiorespiratory fitness

THINC-it test for cognitive function; One-leg Standing test for balance assessment; 10-time chair rise test and hand grip test for strength assessment; Åstrand-Ryhming Test for cardiorespiratory fitness. All assessments will be performed at first and last week of inpatient treatment.

BEHAVIORAL

Monitoring of physical activity and sleep

GENEActiv accelerometer will be worn on the wrist daily during 8-week inpatient treatment.

BEHAVIORAL

Monitoring of self-rated exhaustion, mood and tension

Using the customized PsyMate app.

Sponsors & Collaborators

  • Arno Schmidt-Trucksäss

    lead OTHER

Principal Investigators

  • Arno Schmidt-Trucksäss, Prof. · University of Basel

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-08
Primary Completion
2024-04-30
Completion
2024-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05874856 on ClinicalTrials.gov